An unwanted side effect of hydroxyurea in a patient with idiopathic myelofibrosis
| Autor: | M. M. F. Fickers, M. J. F. Starmans-Kool, M. A. G. Pannebakker |
|---|---|
| Rok vydání: | 1995 |
| Předmět: |
Male
Drug medicine.medical_specialty Fever Side effect media_common.quotation_subject medicine.medical_treatment Gastroenterology Hydroxycarbamide Internal medicine medicine Humans Hydroxyurea Myelofibrosis Aged media_common Chemotherapy Hematology business.industry General Medicine medicine.disease Surgery Discontinuation Primary Myelofibrosis Complication business medicine.drug |
| Zdroj: | Annals of Hematology. 70:279-280 |
| ISSN: | 1432-0584 0939-5555 |
| DOI: | 10.1007/bf01784049 |
| Popis: | A patient with idiopathic myelofibrosis is reported who developed a drug fever after treatment with hydroxyurea, a generally effective and well-tolerated drug in chronic myeloproliferative syndromes. Typically, this form of fever develops after a few weeks of exposure to the drug and disappears with discontinuation of the drug. Possible interactions with prostaglandin or leukotriene metabolism may play a role. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink